Insurance covers approved SMA therapies in the USA, Europe and many developed nations, despite high prices. Families there have access to proven, effective treatment. Stem-cell therapy is self-pay; no registered trials in major centres currently enrol SMA patients for it.
Indicative costs, where offered, are roughly €4,500–€7,500 per course — availability is limited given sparse evidence. For context, approved SMA disease-modifying therapies are extremely expensive but insurance-covered and proven, which sets a high bar: a stem-cell approach would need to match their benefit to justify out-of-pocket cost. The figure is indicative only.
Am I a candidate? → · Spinal Muscular Atrophy: full overview → · Spinal Muscular Atrophy cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.
Évaluation médicale gratuite